United States-Abraham Accords Cooperation and Security Act of 2025
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Overview
This bill establishes an Abraham Accords Office within the Food and Drug Administration (FDA). The office will provide technical assistance to regulatory partners in countries that have signed the Abraham Accords Declaration, focusing on strengthening regulatory oversight of medical products. It will also facilitate information sharing and interactions between the FDA and these countries, with a report to Congress detailing the office’s progress and recommendations for improvement.
Key provisions
- Creates an Abraham Accords Office within the FDA.
- The office will be headed by a director and staffed by FDA personnel.
- The office will provide technical assistance to regulatory partners in Abraham Accords countries.
- The office will facilitate information sharing and interactions between the FDA and relevant parties.
- The Department of State will identify Abraham Accords countries based on the Abraham Accords Declaration.
- The Secretary of Health and Human Services will submit a report to Congress on the office’s activities and recommendations.
Who is affected
- Food and Drug Administration
- Abraham Accords countries
- Manufacturers of regulated products
- Regulatory partners in Abraham Accords countries
- United States Government
Notable changes
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
7 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours